Mar 29, 2020 | BALTIMORE – Complete Omics’ Clinical Proteomics team announced a collaboration with, MSKCC, a world leader in cancer care on a variety of molecular diagnostics projects.
Built upon our unique multi-omics diagnostics platform and MSKCC’s leading position in FDA-approved clinical genomics-based molecular diagnostics, we initiated numerous collaborating cutting-edge projects for a better health of all cancer patients and the entire human population. Please check back soon for our latest progress…
